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Objective: This study aims to reveal the morphological, histological, and immuno-
histochemical mechanism of pannus formation using resected pannus tissue from
patients with prosthetic valve dysfunction.
Method: Eleven patients with prosthetic valve (St Jude Medical valve) dysfunction
in the aortic position who underwent reoperation were studied. We used specimens
of resected pannus for histological staining (hematoxylin and eosin, Grocott’s, azan,
elastica van Gieson) and immunohistochemical staining (transforming growth fac-
tor-beta, transforming growth factor-beta receptor 1, -smooth muscle actin,
desmin, epithelial membrane antigen, CD34, factor VIII, CD68KP1, matrix metal-
loproteinase-1, matrix metalloproteinase-3, and matrix metalloproteinase-9).
Results: Pannus without thrombus was observed at the periannulus of the left
ventricular septal side; it extended into the pivot guard, interfering with the movement
of the straight edge of the leaflet. The histological staining demonstrated that the
specimens were mainly constituted with collagen and elastic fibrous tissue accompanied
by endothelial cells, chronic inflammatory cells infiltration, and myofibroblasts. The
immunohistochemical findings showed significant expression of transforming growth
factor-beta, transforming growth factor-beta receptor 1, CD34, and factor VIII in the
endothelial cells of the lumen layer; strong transforming growth factor-beta receptor 1,
-smooth muscle actin, desmin, and epithelial membrane antigen in the myofibroblasts
of the media layer; and transforming growth factor-beta, transforming growth factor-
beta receptor 1, and CD68KP1 in macrophages of the stump lesion.
Conclusions: Pannus appeared to originate in the neointima in the periannulus of the
left ventricular septum. The structure of the pannus consisted of myofibroblasts and
an extracellular matrix such as collagen fiber. The pannus formation after prosthetic
valve replacement may be associated with a process of periannular tissue healing via
the expression of transforming growth factor-beta.
Prosthetic valve dysfunction (PVD) due to thrombus and pannus for-mation is an infrequent but serious complication. In particular, pa-tients with complete obstruction of the prosthetic valve may developacute hemodynamic deterioration, a life-threatening condition.1
Several clinical and histological studies have reported an occurrence of pannus
formation in patients who received prosthetic valve replacement2-6 and mitral valve
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repair.7 The mechanisms of pannus formation in children
have been reported to be associated with endocardial fibro-
elastosis8 and pseudoxanthoma elasticum.9 The operative
findings demonstrated a narrowing of the orifice of the
aortic prosthetic valve due to pannus overgrowth arising
from the periannular tissue and an obstruction of leaflet
movement.1,3-7,10
The cause of pannus is generally recognized as a biore-
action to the prostheses2,3,7; however, the detailed mecha-
nism of its formation has not yet been fully demonstrated.
Because PVD due to pannus formation is infrequent and
asymptomatic,3-5 effective diagnostic and therapeutic meth-
ods to manage this complication have not been established.
Although reoperations are necessary for cases with marked
deterioration of prosthetic valve function, postoperative
mortality has been reported to be high.5,6 Therefore, further
basic studies are essential for the prevention, diagnosis, and
treatment of pannus formation. The aim of the present study
is to elucidate the morphological, histological, and immu-
nohistochemical mechanisms of pannus formation using
resected pannus tissue from patients with PVD.
Materials and Methods
Patients
Of 615 patients who underwent aortic valve replacement (AVR)
with a St Jude Medical (SJM) valve (St Jude Medical, Inc, St Paul,
Minn) at the Kurume University School of Medicine between 1980
and 1999, 12 cases (11 patients) undergoing reoperations for PVD
in the aortic position were diagnosed by cineradiography and
Doppler echocardiography.10 The incidence of PVD in the aortic
position due to pannus formation was 1.95% (12/615) during this
period. Among these patients, 11 resected specimens were used in
the present study. There were 3 male and 7 female patients, whose
ages ranged from 49 to 69 years of age (mean 63.9  5.8 years) at
the time of reoperation. The period between the prior operation and
reoperation ranged from 22 to 170 months (mean 83  52
months). The primary valve lesions were aortic stenosis in 6 cases
and aortic regurgitation in 5. Two cases had re-AVR and 2 had
AVR and mitral valve replacement. The prothrombin time-inter-
national normalized ratio (PT-INR) at the time of diagnosis of
PVD ranged from 1.43 to 2.05 (mean 1.70 0.16). Preoperatively,
8 patients were classified as New York Heart Association func-
tional class II and 3 were classified as class III.
The diagnosis of PVD was based on the results of cineradiog-
raphy and Doppler echocardiography, as described previously.10
The opening angles ranged from 36° to 86° (mean 53  18°),
calculated as the distance between the 2 leaflets in the fully open
position. The peak pressure gradients by Doppler echocardiogra-
phy ranged from 29.7 to 86.0 mm Hg (mean 50.1  17.1 mm Hg)
calculated with a modified Bernoulli equation (p  PV2  4,
where p is the pressure gradient and PV is the maximal velocity in
meters per second).
Reoperations were performed through a repeat median sternot-
omy. The standard cardiopulmonary bypass was established with
the aortic and both vena caval cannulations, and systemic hypo-
thermia was maintained at 28°C. The operative procedure con-
sisted of re-AVR in 9 cases, aortic root replacement with a com-
posite graft in 1, and pannus resection in 1.
Pannus formation was classified by the categories reported by
Vitale and colleagues.3 The morphologic patterns of the pannus
were classified as either concentric (ie, with regular, circular
ingrowth tissue over the prosthesis) or eccentric (ie, with irregular,
noncircular pannus over localized, protruding edges of the pros-
thesis). These morphologic locations were classified by their po-
sitions (left ventricular, aortoventricular, or aortic). The associa-
tion of thrombi with pannus and their positions on the prosthetic
surfaces were also assessed.
Immunohistochemistry
Resected pannus tissue samples obtained during surgery were
fixed in 10% buffered formalin immediately. All tissues were
embedded in paraffin within 48 hours of formalin fixation and cut
at 4-m intervals according to the standard protocol11-15 just
before staining. Histological staining was performed using hema-
toxylin and eosin (HE), Grocott’s, azan, and elastica van Gieson
stains. Immunohistochemistry was conducted using Histofine rab-
bit or goat streptavidin-biotin peroxidase kits (SAB-PO (M) or (G),
Nichirei Corporation, Tokyo, Japan). Antibodies for immunohis-
tochemical staining were as follows: transforming growth factor-
beta (TGF-), transforming growth factor-beta receptor type 1
(TGF--R1), CD34 (endothelial cell marker), CD68KP1, matrix
metalloproteinase (MMP)-1, MMP-3, MMP-9 (Novocastra Labo-
ratories, Ltd, Newcastle, UK); -smooth muscle actin (-SMA),
desmin, epithelial membrane antigen (EMA), factor VIII (Immu-
non, Pittsburgh, Pa). The effectiveness of serial immunohisto-
chemical sections was confirmed by the expression of each posi-
tive control section. Negative control sections were processed in an
identical manner by substitution of primary antibody with normal
mouse immunoglobulin 1. Peroxidase reaction was developed by
using 3,3'-diaminobenzidine/H2O2 substrate solution.11-14
Immunohistochemical staining was performed for smooth mus-
cle cells (SMCs), including myofibroblasts, which were specified
with -SMA.13,15,16,17 The synthetic and contractile SMC pheno-
types were specified with desmin.18 EMA was specified by immu-
nohistochemical staining in epithelial cells, squamous cells,
plasma cells, and myofibroblasts. Immunohistochemical staining
was performed for macrophages, including foreign body giant
cells, which were specified with CD68KP1.19 Immunohistochem-
ical staining was performed for endothelial cells, which were
specified with CD34 and factor VIII. TGF-, TGF--
R1,14,15,17,20,21 and MMPs16,22 were specified by immunohisto-
chemical staining in the cytokine secreted by macrophages, leu-
kocytes, fibroblasts, and myofibroblasts.
An assessment of each immunohistochemical staining was per-
formed by our pathologists. The results were expressed semi-
quantitatively as follows: “” represents a proportion of one third
or less of positively stained cells; “” represents a proportion of
two thirds, and “” represents a proportion of more than two
thirds of positively stained cells.15
Results
Operative findings did not reveal structural malfunctions in
all SJM valves. All pannus formation was observed at the
septum of the left ventricle. The pannus extended into the
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pivot guard from the sewing cuff and had 2 linear prints
(Figure 1, A; black arrows), interfering with the movement
of the straight edge of the leaflet in the pivot guard.
As for morphologic location, 8 cases had pannus on the
left ventricular side and 3 cases on the aortoventricular side.
Six cases had concentric morphologic patterns and 5 cases
had eccentric patterns. Thrombi associated with pannus
formation were observed in 2 cases. The thrombi were
located on the aortoventricular and aortic side in the leaflet
surface and hinge, and were extended from pannus.
Histological analyses showed that pannus tissue was
comprised of the following 3 distinctive layers and a lesion
(Figure 1, B): a lumen layer (L) in the surface of pannus, an
internal medial layer (IM), an external medial layer (EM),
and a stump lesion located between the autologous annular
tissue and the prosthetic valve (Figures 2, D; 3, B; and 4,
D).
The specimens consisted of the endothelial cells in the
lamina layer (Figure 2, A), chronic inflammatory cell infil-
tration (neutrophils, lymphocytes, plasma cells, macro-
phages, foreign body giant cells, and mast cells), pleomor-
phic spindle cells such as myofibroblasts, and capillary
vessels (Figures 1, B; 2, A, C, and D). Neither malignant
cells, calcifications, nor cavitations were found in the pan-
nus specimens. Bacteria and fungi were also not found in
the pannus specimens with HE and Grocott’s staining.
The internal media layer showed proliferation of spindle
cells arranged in whorled pattern and edematous or myxo-
matous stromal change (Figure 2, C). However, hyalinized
collagen fibers were observed in the external media layer
(Figure 2, B).
The infiltration of chronic inflammatory cells, such as
macrophages and foreign body giant cells, was observed
around the sewing cuff in the stump lesions. However,
overgrowth of spindle cells such as myofibroblasts was
rarely observed in the lesions (Figure 2, D).
TGF- was expressed in the endothelial cells of the
lumen layer and in the chronic inflammatory cells, including
macrophages and foreign body giant cells of the stump
lesion (Figure 3, A, B). However, TGF- was not expressed
in the pleomorphic spindle cells of the media layer.
TGF--R1 (Figure 3, C, D), -SMA (Figure 4, A, B),
desmin, and EMA were significantly expressed in the spin-
dle cells. TGF--R1 was detected in the endothelial cells of
the lumen layer and in the macrophages and foreign body
giant cells in most of the pannus specimens. These spindle
cells were identified as myofibroblasts based on their im-
munohistochemical patterns.
CD34 and factor VIII (Figure 4, C) were expressed in the
endothelial cells of the lumen layer. CD68KP1 was ex-
pressed in macrophages and foreign body giant cells of the
stump lesion around the sewing cuff (Figure 4, D). MMPs
(MMP-1, MMP-3, and MMP-9) were not expressed in all
specimens. These results are summarized in Table 1. The
staining ratio of immunohistochemical staining (except
MMP-1, -3, and -9) semi-quantitatively ranged from 73%
Figure 1. A, The pannus showed two linear prints (indicated by black arrows). B, The histological finding of pannus
allowed for the classification of three unique layers: lumen (L), internal medial layer (IM), and external medial layer
(EM), at 50 magnification with HE staining.
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(8/11) to 100% (11/11). All MMP-1, -3, and -9 staining was
negative.
Discussion
This study examined whether chronic inflammatory reac-
tions and periannular wound healing after AVR contribute
to neointimal response (ie, pannus overgrowth). In the
present study we found that pannus was observed at the
septum of the left ventricle and it extended into the pivot
guard, interfering with the movement of the straight edge of
the leaflet. Proliferation of myofibroblasts was observed
frequently between the lumen layer and the internal media
layer of pannus tissue. The inflammatory reaction was
mainly composed of chronic inflammatory cell infiltration
(neutrophils, lymphocytes, plasma cells, macrophages, for-
eign body giant cells, and mast cells). This inflammatory
reaction was also observed around the sewing cuff at the
stump lesion. Pannus consisted mostly of collagen and
elastic fibrous tissue, suggesting pannus formation resulted
from an accumulation of a generated extracellular matrix.
Strong TGF--R1 expression could be identified in myofi-
broblasts that were specified with -SMA. These findings
suggested pannus formation is due to persistent neointimal
development by protracted chronic inflammatory response,
which provokes proliferation of myofibroblasts and extra-
cellular matrix without fresh thrombus formation.
The results of our study coincided with those of earlier
histological studies conducted by Schoen2 and Vitale and
colleagues.3 Recent clinical and histological studies have
shown that pannus formation was also observed around the
prosthetic ring after mitral valve repair.7 Our previous stud-
ies10,23 demonstrated that asymptomatic PVD in the aortic
position was more frequent than we expected and that the
cause may be related to periannular pannus formation.1
Therefore, these studies suggested that overgrowth of peri-
annular pannus may be associated with persistent inflam-
mation caused by the prosthesis.
All patients receiving prosthetic valve replacement have
a risk of periannular intimal thickening. However, pannus
formation is an infrequent complication. We thus hypothe-
sized that the development of pannus overgrowth during the
follow-up period is related to other factors. Therefore, we
examined the expression of growth factor for neointimal
thickening and the expression of inhibiting factor for extra-
cellular matrix (such as collagenase), based on the hypoth-
esis of coronary restenosis by Schwartz and colleagues.13
Several biochemical growth factors have been shown to
be implicated in the rapid formation of neointimal hyper-
plasia.14,17 Of these, TGF- was reported to be involved in
extracellular matrix production and SMC migration and
proliferation.14,17,20 An increase in TGF-1 expression may
provoke a differentiation signal to trigger adventitial fibro-
blasts to become myofibroblasts, which causes arterial re-
modeling via their mechanical and synthetic properties as
seen in coronary restenosis after percutaneous coronary
intervention.17 Several studies24-26 have shown that fibro-
Figure 2. A, Endothelial cells in the lumen layer. B, Collagen and elastic fibrous tissue in the external media were
observed. C, Myofibroblasts in the internal media. D, Chronic inflammatory cell infiltration was observed in the
stump lesions. The lumen layer is shown at the top of the figure. Magnification 200 (A), 200 (B), 200 (C), and
100 (D).
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genesis and organ remodeling may occur via the expression
of TGF- within the neointima of implant devices or in the
anastomotic site in patients receiving allogenic vessel graft-
ing, artificial vessel grafting, ventricular assist devices, or
coronary artery bypass grafting. Therefore, the neointimal
hyperplasia via the TGF- expression may also be impli-
cated in pannus formation. On the other hand, no expression
of MMP-1, -3, or -9 (which were used because these factors
are classified into collagenases, gelatinases membrane-type
MMPs, and stromelysins based on their individual in vitro
substrate specificity and they inhibit neointima develop-
ment) was found in this study. Therefore, it is unlikely that
matrix remodeling by MMP-1, -3, and -9 caused the devel-
opment of pannus tissue. Consequently, these results sug-
gest that excessive pannus overgrowth is related to the
proliferation of myofibroblasts and extracellular matrix,
stimulated by TGF-. However, the various MMPs are
complex and different in their functions and activities, es-
pecially activity of MMP-2 and -9, which inhibits smooth
muscle cell migration found in dense fibrous tissue in the
arterial wall.16 We are planning to perform a prospective
study with immunoblotting and MMP zymogram to be
certain that MMPs do not play a significant role in pannus
formation.
Some coexisting factors, such as prosthetic valve design,
biocompatibility, surgical techniques, prosthetic valve size
in cases of smaller annuli, blood flow turbulence, shear
stress, and inadequate anticoagulation, may also contribute
to pannus formation.3,27,28 In particular, we are concerned
about the design of pivot guard systems in the SJM valve.
The SJM valve has a characteristic pivot system, a so-called
“low-profile structure.” The clearance between the edge of
the pivot guard and the straight edge of the leaflet is con-
siderably narrow in the fully open position. Therefore, pan-
nus tissue easily extended into the pivot guard and inter-
fered with the leaflet motion.1,23 Moreover, because pannus
in this study was observed in the anterior septum of the left
ventricle in all patients, the contact between the edge of the
pivot guard and the septum may also contribute to this
complication. Other factors, such as local hemodynamics
and shear stress in the vicinity of the pivot guard, may also
be associated with thrombus formation and neointimal hy-
perplasia. In the present study, however, the association
between these factors and pannus formation was not inves-
tigated and the precise mechanisms remain to be elucidated.
Inadequate anticoagulation in patients with prosthetic
valves was considered a risk factor not only for thrombosed
valves but also for pannus formation. Schwartz and col-
leagues13 hypothesized that coronary restenosis is attribut-
able to excessive neointimal formation accompanied by
myofibroblasts and inflammatory cells. According to their
hypothesis, although excessive neointimal hyperplasia in-
Figure 3. A, Expression of TGF- was observed in endothelial cells. B, Expression of TGF- was observed in
macrophages and foreign body giant cells of the stump lesion (* ). C, D, TGF--R1 was significantly expressed in
the endothelial cells of the lumen layer and in myofibroblasts, macrophages, and foreign body giant cells in most
of the pannus specimens. The lumen layer is shown at the top of the figure. Magnification200 (A),100 (B),100
(C), and 200 (D).
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duces the tumorous growth of myofibroblasts and SMC,
thrombosis plays an important role in the restenotic neoin-
timal formation that causes restenosis.13 The PT-INR levels
as indices of anticoagulation therapy for patients with pros-
thetic valves are maintained at a slightly lower range in Japan
than those in North American and European countries because
of particular concerns about bleeding complications.29 Because
thrombus can be a primary cause of pannus formation,21,30
further studies are required to assert whether the lower PT-INR
levels observed in this study cause pannus overgrowth.
Study Limitations
We intended to reveal whether the pannus formation was
due to a form of normal healing or abnormal growth of
neointima as we examined the pannus without a comparison
to control autologous tissues. We plan to undertake a pro-
spective study in which pannus and control tissue are ex-
amined to reveal the detailed mechanism of pannus forma-
tion, with better understanding of the precise role of the
local inflammatory response in the vicinity of the sewing
cuff. Moreover, further prospective and quantitative studies
TABLE 1. Results of immunohistochemistry
Stain Target Lumen I. Media E. Media Stump
TGF- TGF-  ● ● 
TGF--R1 TGF-    
-SMA SMC, MFB    
Desmin SMC    
EMA EpC, MFB, PC ●   
CD34 EnC, FB    ●
Factor VIII EnC  ● ● ●
CD68KP1 Mp, Mo ● ● ● 
MMPs MMPs ● ● ● ●
I. Media, Internal medial layer; E. Media, external medial layer; TGF-, transforming growth factor-beta; MMPs, matrix metalloproteinases; SMC, smooth
muscle cell; MFB, myofibroblast; EpC, epithelial cell; EnC, endothelial cell; PC, plasma cell; FB, fibroblast; Mp, macrophage; Mo, monocyte;  represents
a proportion of one third or less of positively stained cells;  represents a proportion of two thirds; and  represents more than two thirds of
positively stained cells; ●, no expression.
Figure 4. A, B, The expression of -SMA was observed in the endothelial cells of the lumen layer and the
myofibroblasts. C, Factor VIII expressed in the endothelial cells of the lumen layer. D, CD68KP1 expressed in
macrophages and foreign body giant cell of the stump lesion around the sewing cuff (* ). The lumen layer is shown
at the top of the figure. Magnification 100 (A), 100 (B), 100 (C), and 200 (D).
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involving more PVD cases with analyses of the composition
and organization of the matrix components, protein synthe-
sis, and genetic information are required.
Conclusions
Pannus appeared to originate in the neointima in the peri-
annulus of the left ventricular septum. The structure of
pannus consisted of myofibroblasts and extracellular matrix.
The pannus formation after prosthetic valve replacement
may be associated with a process of periannular tissue
healing via the expression of TGF-.
We wish to thank Ms Misato Shiraishi for expert technical help
in this study.
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